Australia approves Pfizer COVID-19 vaccine for children aged 12 to 15
SYDNEY: Australia's drug regulator has approved Pfizer-BioNTech's COVID-19 vaccine for use with children aged 12 to 15, Federal Health Minister Greg Hunt said on Friday , as the country fights an outbreak of the Delta variant in three states.
The Therapeutic Goods Administration has thoroughly assessed the domestic and international evidence before extending its approval for the Pfizer-BioNTech vaccine to be administered to this age group, Hunt said in a statement.Similar clearances for the use of the vaccine in children were approved several weeks ago by regulators in the United States, European Union and Britain.
Up until now, the Pfizer-BioNTech vaccine had only been approved for use in Australia for people aged 16 years and over. Australia's vaccination panel will advise on which groups of children should be prioritised for the roll-out of the vaccine and when it should be administered, Hunt said.With just over 32,400 COVID-19 cases and 915 deaths, Australia has handled the pandemic much better than many other developed economies, but stop-and-start lockdowns and a sluggish vaccine roll-out have led to frustration.
Prime Minister Scott Morrison on Thursday apologised for the slow vaccination programme as his government looks to speed up inoculations and meet a target to vaccinate the adult population by end-2021.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study findsTwo doses of Pfizer or AstraZeneca's COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on Wednesday showed. Officials say vaccines are highly effective against the Delta variant, now the dominant variant worldwide, though the study reiterated that one shot of the vaccines is not enough for high protection. The study, published in the New England Journal of Medicine, confirms headline findings given by Public Health England in May about the efficacy of COVID-19 vaccines made by Pfizer-BioNTech and Oxford-AstraZeneca, based on real-world data.
Read more »
Taiwan Buddhist group to buy 5 million BioNTech COVID-19 vaccinesTAIPEI: A major Taiwanese Buddhist group said on Wednesday (Jul 21) it had signed a deal to buy 5 million doses of BioNTech's COVID-19 vaccine via ...
Read more »
Chile approves emergency use of Sputnik-V COVID-19 vaccineChile's Institute of Public Health approved emergency use of the Russian Sputnik-V vaccine against COVID-19, joining the country's already massive ...
Read more »
Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study findsTwo doses of Pfizer or AstraZeneca's COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on Wednesday showed. Officials say vaccines are highly effective against the Delta variant, now the dominant variant worldwide, though the study reiterated that one shot of the vaccines is not enough for high protection. The study, published in the New England Journal of Medicine, confirms headline findings given by Public Health England in May about the efficacy of COVID-19 vaccines made by Pfizer-BioNTech and Oxford-AstraZeneca, based on real-world data.
Read more »
Thailand reports record new COVID-19 cases for second day, apologises for slow vaccine roll-outBANGKOK: Thailand on Thursday (Jul 22) reported 13,655 new COVID-19 cases, a daily record for a second consecutive day and bringing the country's ...
Read more »